Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SPECT And NotBastiaan R. Bloem

List of bibliographic references

Number of relevant bibliographic references: 23.
Ident.Authors (with country if any)Title
000196 Roberto Cilia [Canada, Italie] ; Sang Soo Cho [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; Ji Hyun Ko [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada]Pathological gambling in patients with Parkinson's disease is associated with fronto‐striatal disconnection: A path modeling analysis
000645 Francesco Roselli [Italie, Allemagne] ; Nicola M. Pisciotta [Italie] ; Michele Pennelli [Italie] ; Maria S. Aniello [Italie] ; Angelo Gigante [Italie] ; Maria F. De Caro [Italie] ; Ermanno Ferrannini [Italie] ; Bruno Tartaglione [Italie] ; Artor Niccoli-Asabella [Italie] ; Giovanni Defazio [Italie] ; Paolo Livrea [Italie] ; Giuseppe Rubini [Italie]Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study
000686 Ioannis U. Isaias [Italie] ; Giorgio Marotta [Italie] ; Shigeki Hirano [États-Unis] ; Margherita Canesi [Italie] ; Riccardo Benti [Italie] ; Andrea Righini [Italie] ; Chengke Tang [États-Unis] ; Roberto Cilia [Italie] ; Gianni Pezzoli [Italie] ; David Eidelberg [États-Unis] ; Angelo Antonini [Italie]Imaging essential tremor
000725 David J. Brooks [Royaume-Uni]Examining Braak's hypothesis by imaging Parkinson's disease
000981 David J. Brooks [Royaume-Uni] ; Klaus Seppi [Autriche]Proposed neuroimaging criteria for the diagnosis of multiple system atrophy
000A01 Vicky L. Marshall [Royaume-Uni] ; Cornelia B. Reininger [Allemagne] ; Moritz Marquardt [Allemagne] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Wolfgang H. Oertel [Allemagne] ; Hani T. S. Benamer [Royaume-Uni] ; Paul Kemp [Royaume-Uni] ; David Burn [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Jamie Kulisevsky [Espagne] ; Luis Cunha [Portugal] ; Durval Costa [Portugal] ; Jan Booij [Pays-Bas] ; Klaus Tatsch [Allemagne] ; K. Ray Chaudhuri [Royaume-Uni] ; Gudrun Ulm [Allemagne] ; Oliver Pogarell [Allemagne] ; Helmut Höffken [Allemagne] ; Anja Gerstner [Allemagne] ; Donald G. Grosset [Royaume-Uni]Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT
000B24 Yasushi Osaki [Japon] ; Yukari Morita [Japon] ; Mitsutaka Fukumoto [Japon] ; Naoki Akagi [Japon] ; Shoji Yoshida [Japon] ; Yoshinori Doi [Japon]Cross‐sectional and longitudinal studies of three‐dimensional stereotactic surface projection SPECT analysis in Parkinson's disease
000D03 Roberto Ceravolo [Italie] ; Angelo Antonini [Italie] ; Duccio Volterrani [Italie] ; Carlo Rossi [Italie] ; Lorenzo Kiferle [Italie] ; Daniela Frosini [Italie] ; Claudio Lucetti [Italie] ; Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie]Predictive value of nigrostriatal dysfunction in isolated tremor: A clinical and SPECT study
000D71 Sabina Pappatà ; Elena Salvatore ; Alfredo PostiglioneIn Vivo Imaging of Neurotransmission and Brain Receptors in Dementia
000F61 Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche]Role of DAT‐SPECT in the diagnostic work up of Parkinsonism
000F87 A. Wallin [Suède] ; S. Ekberg [Suède] ; K. Lind [Suède] ; V. Milos [Suède] ; A. Granérus [Suède] ; G. Granerus [Suède]Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson’s disease – a rCBF scintigraphy study
001127 Eduardo Tolosa [Espagne] ; Thierry Vander Borght [Belgique] ; Emilio Moreno [Espagne]Accuracy of DaTSCAN (123I‐ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2‐Year follow‐up of an open‐label study
001432 K. Winge [Danemark] ; L. Friberg [Danemark] ; L. Werdelin [Danemark] ; K. K. Nielsen [Danemark] ; H. Stimpel [Danemark]Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease
001482 J. Eerola [Finlande] ; P J Tienari [Finlande] ; S. Kaakkola [Finlande] ; P. Nikkinen ; J. Launes [Finlande]How useful is [123I]β-CIT SPECT in clinical practice?
001672 Sylvia M. Boesch [Autriche] ; Eveline Donnemiller [Autriche] ; Jörg Müller [Autriche] ; Klaus Seppi [Autriche] ; Helga Weirich-Schwaiger [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I‐βCIT and 123I‐IBZM SPECT study
001683 David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni]Use of functional imaging in parkinsonism and dementia
001714 Werner Poewe [Autriche] ; Christoph Scherfler [Autriche]Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice
001756 Paul K. Morrish [Royaume-Uni]How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?
001795 Walter Pirker [Autriche]Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
001908 K. Marek [États-Unis] ; D. Jennings [États-Unis] ; J. Seibyl [États-Unis]Do dopamine agonists or levodopa modify Parkinson's disease progression?
001923 Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
001991 Tarja H. Haapaniemi [Finlande] ; Aapo Ahonen [Finlande] ; Pentti Torniainen [Finlande] ; Kyösti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande][123I]β‐CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients
001C65 S. Bostantjopoulou [Grèce] ; Z. Katsarou [Grèce] ; D. Zafiriou [Grèce] ; G. Gerasimou [Grèce] ; A. Alevriadou [Grèce] ; G. Georgiadis [Grèce] ; G. Kiosseoglou [Grèce] ; A. Kazis [Grèce]Abnormality of N30 somatosensory evoked potentials in Parkinson’s disease: a multidisciplinary approach
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024